PTC Therapeutics: Q2 Earnings Insights

PTC Therapeutics PTCT reported its Q2 earnings results on Thursday, August 4, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

PTC Therapeutics missed estimated earnings by 60.15%, reporting an EPS of $-2.13 versus an estimate of $-1.33.

Revenue was up $48.85 million from the same period last year.

Last quarter the company missed on EPS by $0.27 which was followed by a 2.66% increase in the share price the next day.

Here's a look at PTC Therapeutics's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-1.51	-1.64	-1.40	-1.82
EPS Actual	-1.78	-2.03	-1.89	-1.68
Revenue Estimate	147.06M	150.83M	126.44M	110.50M
Revenue Actual	148.74M	165.23M	138.74M	116.68M

To track all earnings releases for PTC Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar